Drugs Made In America Acquisition II Corp. Ordinary Shares
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | 0.07 | $0 | -$172,746 |
| 2026 Q1 | 0.07 | $0 | -$102,503 |
| 2025 Q4 | 0.18 | $0 | -$314,864 |
| 2025 Q3 | -0.02 | $0 | -$690,726 |
| 2025 Q2 | 0.00 | $0 | — |
| 2025 Q1 | -0.00 | $0 | — |
| 2024 Q3 |
| 0.00 |
| $0 |
| — |